Prof. Christophe Cataisson is a Staff Scientist at the Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute. He received his Ph.D. from Université d'Auvergne. Dr. Cataisson’s research expertise is centered on skin carcinogenesis (cutaneous squamous cell carcinoma) following two-stage chemical carcinogenesis (DMBA-TPA). He also uses primary mouse keratinocytes to define phenotypic changes caused by oncogenic RAS. He uses genetically modified mouse models to study pathways contributing to carcinogenesis (PKC, MyD88, CXCR2, EGFR, MET, MTOR). Using an in vivo grafting model on a syngeneic host has allowed Dr. Cataisson to probe the respective contribution of cancer cells and their stroma to tumor formation. Dr. Cataisson’s integrated research takes advantage of the ability to use primary cells transformed by a single hit (oncogenic RAS) and exploring their phenotype in vivo in a relevant context.
Prof. Christophe Cataisson is a Staff Scientist at the Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute. He received his Ph.D. from Université d'Auvergne. Dr. Cataisson’s research expertise is centered on skin carcinogenesis (cutaneous squamous cell carcinoma) following two-stage chemical carcinogenesis (DMBA-TPA). He also uses primary mouse keratinocytes to define phenotypic changes caused by oncogenic RAS. He uses genetically modified mouse models to study pathways contributing to carcinogenesis (PKC, MyD88, CXCR2, EGFR, MET, MTOR). Using an in vivo grafting model on a syngeneic host has allowed Dr. Cataisson to probe the respective contribution of cancer cells and their stroma to tumor formation. Dr. Cataisson’s integrated research takes advantage of the ability to use primary cells transformed by a single hit (oncogenic RAS) and exploring their phenotype in vivo in a relevant context.